×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
A Look At The Fair Value Of Marinomed Biotech AG (VIE:MARI)
Simply Wall Street
Key Insights Using the Dividend Discount Model, Marinomed Biotech fair value estimate is €15.73 With €14.65 share...
1 week ago
EQS-News: Marinomed Biotech AG announces results for the first quarter of 2024
OTS.at
EQS-News: Marinomed Biotech AG announces results for the first quarter of 2024. EQS-News: Marinomed Biotech AG / Key word(s): Quarter...
2 weeks ago
EQS-News: Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché ...
OTS.at
EQS-News: Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios. EQS-News: Marinomed...
1 month ago
M8 Pharmaceuticals obtains market authorization for Barlo® (Carragelose®) nasal spray in Mexico
PR Newswire
PRNewswire/ -- M8 pharmaceuticals is pleased to announce the market approval of a Barlo® (Carragelose®) nasal spray in Mexico.
10 months ago
EQS-AGM: Marinomed Biotech AG: Invitation to the 7th Annual General Meeting on Thursday, June 20, 2024, at ...
OTS.at
EQS-AGM: Marinomed Biotech AG: Invitation to the 7th Annual General Meeting on Thursday, June 20, 2024, at 13:00 (Vienna time).
1 week ago
Marinomed Biotech AG Grants Exclusive Rights for Carragelose® to M8 Pharmaceuticals marketed locally as Barlo®
PR Newswire
Share this article · M8 Pharmaceuticals to obtain exclusive rights for marketing Carragelose® in Brazil and Mexico · Carragelose® nasal spray...
34 months ago
Nothing to sneeze at: nasal sprays to tackle Covid-19
Clinical Trials Arena
Pharmaceutical Technology takes a look at some of the nasal sprays in development for the treatment and prevention of Covid-19.
34 months ago
Marinomed Biotech develops novel drug for the treatment of autoimmune gastritis
BioSpectrum Asia
Researchers are developing a medicinal product, that focuses on the anti-inflammatory treatment of autoimmune gastritis. Basis is the technology...
43 months ago
Update: Seaweed-Derived Treatment for Common Cold Approved in the EU
Labiotech.eu
Marinomed Biotech's antiviral drug, which is derived from seaweed, could eventually be used to treat the cause of the common cold in...
70 months ago
EQS-News: Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of ...
OTS.at
EQS-News: Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18...
2 months ago